This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 8-14 October 2023 and includes updates on hepatitis A, influenza A(H5N1), COVID-19, the Rugby World Cup 2023, West Nile virus, measles and diphtheria.
Compared with the 2021‑2022 influenza season, for sentinel surveillance the number of tested specimens has
doubled, with a 4‑fold increase in influenza detections.
This document presents the core protocol for ECDC studies of CVE and IVE against symptomatic laboratory-confirmed influenza or SARS-CoV-2 infection, respectively, at primary care level.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24-30 September 2023 and includes updates on severe floods, Severe floods, Avian influenza, human cases with swine influenza, COVID-19, West Nile Virus, Cholera and mass gathering monitoring for the Rugby World Cup 2023.
This report provides an overview of highly pathogenic avian influenza (HPAI) virus detections in poultry, captive and wild birds that occurred in and outside Europe between 24 June and 1 September 2023, as well as HPAI virus detections in mammals (up to 15 September 2023) and human cases due to avian influenza virus (up to 14 September
2023).
This document describes a risk-based targeted approach to identifying possible avian influenza virus infections through established routine respiratory virus surveillance systems during the winter season 2023/24.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 September 2023 and includes updates on COVID-19, diphtheria, West Nile virus, avian influenza, dengue, legionnaires' disease, the Rugby World Cup 2023, cutaneous Anthrax, pertussis, botulism and severe floods.
To improve the understanding of experienced HIV stigma in the community, ECDC initiated an exploratory survey in 2021 to measure HIV-related stigma across Europe and Central Asia.
This evidence brief summarises the progress towards UN Sustainable Development Goal 3.3 to ‘eliminate the epidemic of AIDS’ in Europe and Central Asia.